Flexion Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (8)

Latest Posts

About This Stock More About This Stock
3 Biotech And Pharma Stocks With Key FDA Catalysts This October
Article By: Arpita Dutt
Monday, October 2, 2017 10:16 AM EST
The FDA, which approved 22 novel drugs last year, has given its approval to 34 drugs so far in 2017 including three in September.
In this article: FLXN, ALXN, PTCT Also: JNJ, TSRO, ACRX, AERI
Read
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Article By: Arpita Dutt
Monday, July 17, 2017 11:35 AM EST
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read
Sanofi To Buy Flexion Therapeutics, Inc. For +$1 Billion In Cash
Article By: Lorimer Wilson
Thursday, March 23, 2017 6:04 PM EST
Sanofi is in talks to buy Flexion Therapeutics, Inc. a Boston-area biotech with its lead product now awaiting FDA approval, for more than $1 billion in cash, according to a source close to the deal.
In this article: SNY, FLXN Also: JNJ, PFE
Read
Flexion Therapeutics Announces Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, November 15, 2016 5:35 PM EST
Flexion Therapeutics, Inc. today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell shares of its common stock.
In this article: FLXN
Read
Flexion Therapeutics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, June 7, 2016 6:06 PM EST
Flexion Therapeutics, Inc. today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $60.0 million of shares of its common stock.
In this article: FLXN
Read

PARTNER HEADLINES

Latest Tweets for $FLXN

No tweets yet!